The latest evidence in the Management of Neuromuscular Blockade
News: Uppsala, June 3, 2020. Senzime AB (publ) today announces that they are the proud sponsorof a free webinar on the management of neuromuscular blockade.This educational webinar is designed to provide insight into the latest evidence of post-operative residual neuromuscular blockade, antagonist strategies to reduce PORC and atechnology review of current monitoring technologies.Meet the experts and join us on Wednesday June 17[th]! Space is limited, book your place here: REGISTER LINK: Early session